Skip to main content
icon for Cyclosporiasis cases in U.S. by July 31?

Cyclosporiasis cases in U.S. by July 31?

icon for Cyclosporiasis cases in U.S. by July 31?

Cyclosporiasis cases in U.S. by July 31?

BAGO
Jul 31, 2026
Polymarket

$1,142 Vol.

Polymarket

1800+

$164 Vol.

94%

2000+

$47 Vol.

64%

2500+

$712 Vol.

85%

3000+

$177 Vol.

65%

5000+

$42 Vol.

20%

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of mid-July 2026, CDC surveillance shows the typical seasonal rise in cyclosporiasis cases driven by foodborne transmission of Cyclospora cayetanensis oocysts in contaminated fresh produce such as berries and leafy greens. Confirmed case counts remain consistent with historical summer patterns rather than indicating a large multistate outbreak, supporting trader focus on whether totals will exceed baseline thresholds by July 31. Key variables include import volumes, produce sourcing changes, and any new clusters identified through notifiable disease reporting. CDC's ongoing weekly or monthly updates on laboratory-confirmed cases will provide the next authoritative data releases that could shift market-implied odds.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$1,142
Petsa ng Pagtatapos
Jul 31, 2026
Binuksan ang Market
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of mid-July 2026, CDC surveillance shows the typical seasonal rise in cyclosporiasis cases driven by foodborne transmission of Cyclospora cayetanensis oocysts in contaminated fresh produce such as berries and leafy greens. Confirmed case counts remain consistent with historical summer patterns rather than indicating a large multistate outbreak, supporting trader focus on whether totals will exceed baseline thresholds by July 31. Key variables include import volumes, produce sourcing changes, and any new clusters identified through notifiable disease reporting. CDC's ongoing weekly or monthly updates on laboratory-confirmed cases will provide the next authoritative data releases that could shift market-implied odds.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$1,142
Petsa ng Pagtatapos
Jul 31, 2026
Binuksan ang Market
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

Mag-ingat sa mga external link.

Mga Madalas na Tanong

Ang "Cyclosporiasis cases in U.S. by July 31?" ay isang prediction market sa Polymarket na may 5 posibleng outcomes kung saan bumibili at nagbebenta ang mga trader ng shares batay sa kanilang pinaniniwalaan na mangyayari. Ang kasalukuyang nangunguna ay "1800+" sa 94%, sinusundan ng "2500+" sa 85%. Ang mga presyo ay sumasalamin sa real-time crowd-sourced probabilities. Halimbawa, ang isang share na naka-presyo sa 94¢ ay nagpapahiwatig na kolektibong itinatakda ng market ang 94% na tsansa sa outcome na iyon. Patuloy na nagbabago ang mga odds na ito habang tumutugon ang mga trader sa mga bagong development at impormasyon. Ang mga shares sa tamang outcome ay mare-redeem sa $1 bawat isa sa market resolution.

Ang "Cyclosporiasis cases in U.S. by July 31?" ay isang bagong likhang market sa Polymarket, inilunsad noong Jul 14, 2026. Bilang isang maagang market, ito ang iyong pagkakataon na maging kabilang sa mga unang trader na magtakda ng odds at mag-establish ng mga paunang price signal ng market. Maaari mo ring i-bookmark ang pahinang ito para subaybayan ang volume at trading activity habang lumalaki ang market sa paglipas ng panahon.

Para mag-trade sa "Cyclosporiasis cases in U.S. by July 31?," i-browse ang 5 available na outcomes na nakalista sa pahinang ito. Ang bawat outcome ay may kasalukuyang presyo na kumakatawan sa implied probability ng market. Para kumuha ng posisyon, piliin ang outcome na pinaniniwalaan mong pinaka-malamang, piliin ang "Yes" para mag-trade pabor dito o "No" para mag-trade laban dito, ilagay ang iyong halaga, at i-click ang "Trade." Kung tama ang iyong napiling outcome kapag na-resolve ang market, nagbabayad ang iyong "Yes" shares ng $1 bawat isa. Kung mali, nagbabayad ang mga ito ng $0. Maaari ka ring magbenta ng iyong shares anumang oras bago ang resolution kung gusto mong i-lock in ang kita o bawasan ang pagkalugi.

Ang kasalukuyang frontrunner para sa "Cyclosporiasis cases in U.S. by July 31?" ay "1800+" sa 94%, ibig sabihin itinatakda ng market ang 94% na tsansa sa outcome na iyon. Ang sumunod na pinaka-malapit na outcome ay "2500+" sa 85%. Nag-a-update ang mga odds na ito sa real-time habang bumibili at nagbebenta ang mga trader ng shares, kaya sinasalamin nila ang pinakabagong kolektibong view kung ano ang pinaka-malamang na mangyari. Bumalik nang madalas o i-bookmark ang pahinang ito para sundan kung paano nagbabago ang odds habang lumilitaw ang bagong impormasyon.

Ang mga resolution rules para sa "Cyclosporiasis cases in U.S. by July 31?" ay tiyak na nagde-define kung ano ang kailangang mangyari para sa bawat outcome na maideklara bilang panalo — kasama ang mga opisyal na data source na ginagamit para matukoy ang resulta. Maaari mong i-review ang kumpletong resolution criteria sa "Rules" section sa pahinang ito sa itaas ng mga komento. Inirerekomenda namin na basahin nang mabuti ang mga patakaran bago mag-trade, dahil tinutukoy nila ang mga tiyak na kondisyon, edge cases, at mga source na namamahala kung paano nise-settle ang market na ito.